New research reveals konjac glucomannan’s significant effects on glucose metabolism and gut microbiota, offering promising solutions for obesity management. Groundbreaking studies demonstrate ko...
New research reveals how time-restricted eating improves metabolic health through gut microbiome modulation, with clinical benefits for diabetes and obesity management. Emerging science demonstrates T...
Recent studies highlight curcumin’s potential in managing diabetes and hypertension, with new formulations enhancing bioavailability and clinical efficacy. New research reveals curcumin’s ...
Recent study reveals KGM’s benefits on glucose, lipid metabolism, and gut microbiota in obese mice, with potential applications for human metabolic health. New research highlights konjac glucoma...
New research reveals konjac glucomannan’s unique ability to modulate gut microbiota and improve metabolic markers through different intake forms, offering novel obesity management strategies. Cu...
New research reveals konjac glucomannan’s unique ability to combat obesity through mechanical and biochemical mechanisms, with frozen gel form showing 18% greater efficacy in mice studies. Cutti...
New research reveals prenatal PFAS exposure may impair maternal beta cell function long-term, increasing diabetes risk amid widespread contamination concerns. Groundbreaking study connects prenatal PF...
New research highlights konjac glucomannan’s potential in weight management and metabolic health through gut microbiota modulation and SCFA production. Recent studies demonstrate konjac glucoman...
New research reveals KGM sol reduces insulin resistance 40% and boosts GLP-1 2.1-fold in obese mice, with emerging clinical evidence supporting human applications. Groundbreaking mouse studies demonst...
New research reveals how modified forms of konjac glucomannan differentially impact glucose and lipid metabolism in obesity through gut microbiota alterations. Cutting-edge studies demonstrate konjac ...
